Is iTeos Belgium still active?

Yes, iTeos Belgium is currently active.

Where is iTeos Belgium registered?

iTeos Belgium's registered address is Rue de Venise 21, 6040 Charleroi, Belgium.

How many employees does iTeos Belgium have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2024), iTeos Belgium reported 128.1 full-time equivalent employees.

What is iTeos Belgium's annual turnover?

iTeos Belgium's most recently filed annual turnover (fiscal year ending 31 Dec 2024) was €32,542,096.

Did iTeos Belgium make a profit or a loss?

iTeos Belgium's most recently filed annual accounts (fiscal year ending 31 Dec 2024) reported a profit of €40,832,691.

When did iTeos Belgium last file annual accounts?

iTeos Belgium's most recently filed annual accounts cover the fiscal year ending 31 Dec 2024.

Is iTeos Belgium B Corp certified?

We have no B Corp certification on file for iTeos Belgium.

Does iTeos Belgium hold Fairtrade certification?

No, iTeos Belgium does not currently hold Fairtrade certification.

iTeos Belgium

Q: When was iTeos Belgium founded?

iTeos Belgium was founded on 01 Aug 2011, making it 15 years old.

Q: What does iTeos Belgium do?

iTeos Belgium's registered main activities are Research and experimental development on biotechnology, Intermediation service activities for real estate activities, Organisation of conventions and trade shows, Systematic studies and creative efforts undertaken in various types of math research and development and natural sciences (physics, astronomy, chemistry, medical sciences, biology, etc.), Manufacture of basic pharmaceutical products, Manufacture of medicaments, Research and experimental development on other natural sciences and engineering, and Study, development of the production of active ingredients for drug manufacturing.

BE 0838.316.659

Copied!

NV/SA

Status

Active

Founded

01 Aug 2011 · 15 yrs

Size

Medium · 128.1 FTE

Abbreviation

ITEOS

Main activity

Research and experimental development on biotechnology

Website

iteostherapeutics.com

Activities

8 activities

Research and experimental development on biotechnologyIntermediation service activities for real estate activitiesOrganisation of conventions and trade showsSystematic studies and creative efforts undertaken in various types of math research and development and natural sciences (physics, astronomy, chemistry, medical sciences, biology, etc.)Manufacture of basic pharmaceutical productsManufacture of medicamentsResearch and experimental development on other natural sciences and engineeringStudy, development of the production of active ingredients for drug manufacturing

Financials

Turnover2024

€32.5M+204.5%

Profit / Loss2024

€40.8M+369.8%

Equity2024

€91M-80.4%

2024	2023	2022	2021
€32,542,096+204.5%	€10,685,580-95.3%	€227,054,816-22.4%	€292,504,789
€40,832,691+369.8%	-€15,134,104-108%	€190,000,844-26.6%	€258,822,734
€91,011,200-80.4%	€464,836,321-3.9%	€483,762,311+63.2%	€296,396,907
€51,195,742+33.5%	€38,354,754-23.2%	€49,923,767-82.5%	€284,666,959
€2,586,913-82.4%	€14,683,310-23.4%	€19,166,850-51%	€39,119,396
128.1+18.4%	108.2+30.2%	83.1+31.7%	63.1
€254,037+157.2%	€98,758-96.4%	€2,732,308-41.1%	€4,635,575

Frequently asked questions

01What is iTeos Belgium's official registered name?

iTeos Belgium.

02What is iTeos Belgium's enterprise number (VAT number)?

BE 0838.316.659.

03What is iTeos Belgium's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

04When was iTeos Belgium founded?

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2024	2023	2022	2021
Income statement
	€32,542,096+204.5%	€10,685,580-95.3%	€227,054,816-22.4%	€292,504,789
	€25,371,961+23%	€20,635,088+47.3%	€14,008,312+38.9%	€10,088,396
	-€32,486,195+3%	-€33,485,930-118.8%	€177,646,394-30.3%	€255,007,635
	€40,832,691+369.8%	-€15,134,104-108%	€190,000,844-26.6%	€258,822,734
	€123,994-2.8%	€127,546-74.3%	€495,761+196%	€167,473
Profitability
	125.5%+188.6%	-141.6%-269.2%	83.7%-5.4%	88.5%
	44.9%>1000%	-3.3%-108.3%	39.3%-55%	87.3%
	28.7%>1000%	-3.0%-108.4%	35.6%-20.1%	44.5%
Solvency
	€142,206,943-71.7%	€503,191,074-5.7%	€533,686,078-8.1%	€581,063,866
	€4,572,675+15.2%	€3,969,355+164.2%	€1,502,585-0.6%	€1,512,109
	€150,557-100%	€382,347,252-12%	€434,717,486-8.9%	€477,117,043
	€91,011,200-80.4%	€464,836,321-3.9%	€483,762,311+63.2%	€296,396,907
	64.0%-30.7%	92.4%+1.9%	90.6%+77.7%	51.0%
	€6,352,013-6.4%	€6,784,056-3.4%	€7,021,793	—
	0.07+378.2%	0.01+0.6%	0.01	—
	€51,195,742+33.5%	€38,354,754-23.2%	€49,923,767-82.5%	€284,666,959
	0.56+581.7%	0.08-20%	0.10-89.2%	0.96
	-361.97+41.1%	-614.51-115.8%	3895.56+130.1%	1692.84
Liquidity
	€2,586,913-82.4%	€14,683,310-23.4%	€19,166,850-51%	€39,119,396
	€14,043,403+71.7%	€8,177,892-57.4%	€19,205,123+22.3%	€15,704,428
	€32,343,004+61.8%	€19,994,918+0.2%	€19,952,559-39.9%	€33,184,923
	€39,702,881+48.1%	€26,815,046+8%	€24,836,521-29.5%	€35,211,432
	1.71-4.4%	1.79+70.8%	1.05+598.2%	0.15
	€34,349,548-13.1%	€39,552,670+86.7%	€21,182,582+110.4%	-€202,862,178
Efficiency
	158 days-43.6%	279 days+804.9%	31 days+57.5%	20 days
Profit appropriation
	€411,507,230	—	—	—
	€913,3520%	€913,3520%	€913,3520%	€913,352
	€40,832,691-90.1%	€411,507,230-3.5%	€426,641,333+80.3%	€236,640,489

Sources

NBB — Nationale Bank van België

	2024	2023	2022	2021
Income statement
	€32,542,096+204.5%	€10,685,580-95.3%	€227,054,816-22.4%	€292,504,789
	€25,371,961+23%	€20,635,088+47.3%	€14,008,312+38.9%	€10,088,396
	-€32,486,195+3%	-€33,485,930-118.8%	€177,646,394-30.3%	€255,007,635
	€40,832,691+369.8%	-€15,134,104-108%	€190,000,844-26.6%	€258,822,734
	€123,994-2.8%	€127,546-74.3%	€495,761+196%	€167,473
Profitability
	125.5%+188.6%	-141.6%-269.2%	83.7%-5.4%	88.5%
	44.9%>1000%	-3.3%-108.3%	39.3%-55%	87.3%
	28.7%>1000%	-3.0%-108.4%	35.6%-20.1%	44.5%
Solvency
	€142,206,943-71.7%	€503,191,074-5.7%	€533,686,078-8.1%	€581,063,866
	€4,572,675+15.2%	€3,969,355+164.2%	€1,502,585-0.6%	€1,512,109
	€150,557-100%	€382,347,252-12%	€434,717,486-8.9%	€477,117,043
	€91,011,200-80.4%	€464,836,321-3.9%	€483,762,311+63.2%	€296,396,907
	64.0%-30.7%	92.4%+1.9%	90.6%+77.7%	51.0%
	€6,352,013-6.4%	€6,784,056-3.4%	€7,021,793	—
	0.07+378.2%	0.01+0.6%	0.01	—
	€51,195,742+33.5%	€38,354,754-23.2%	€49,923,767-82.5%	€284,666,959
	0.56+581.7%	0.08-20%	0.10-89.2%	0.96
	-361.97+41.1%	-614.51-115.8%	3895.56+130.1%	1692.84
Liquidity
	€2,586,913-82.4%	€14,683,310-23.4%	€19,166,850-51%	€39,119,396
	€14,043,403+71.7%	€8,177,892-57.4%	€19,205,123+22.3%	€15,704,428
	€32,343,004+61.8%	€19,994,918+0.2%	€19,952,559-39.9%	€33,184,923
	€39,702,881+48.1%	€26,815,046+8%	€24,836,521-29.5%	€35,211,432
	1.71-4.4%	1.79+70.8%	1.05+598.2%	0.15
	€34,349,548-13.1%	€39,552,670+86.7%	€21,182,582+110.4%	-€202,862,178
Efficiency
	158 days-43.6%	279 days+804.9%	31 days+57.5%	20 days
Profit appropriation
	€411,507,230	—	—	—
	€913,3520%	€913,3520%	€913,3520%	€913,352
	€40,832,691-90.1%	€411,507,230-3.5%	€426,641,333+80.3%	€236,640,489

2024

2023

2022

2021

Income statement

€32,542,096+204.5%

€10,685,580-95.3%

€227,054,816-22.4%

€292,504,789

€25,371,961+23%

€20,635,088+47.3%

€14,008,312+38.9%

€10,088,396

-€32,486,195+3%

-€33,485,930-118.8%

€177,646,394-30.3%

€255,007,635

€40,832,691+369.8%

-€15,134,104-108%

€190,000,844-26.6%

€258,822,734

€123,994-2.8%

€127,546-74.3%

€495,761+196%

€167,473

Profitability

125.5%+188.6%

-141.6%-269.2%

83.7%-5.4%

88.5%

44.9%>1000%

-3.3%-108.3%

39.3%-55%

87.3%

28.7%>1000%

-3.0%-108.4%

35.6%-20.1%

44.5%

Solvency

€142,206,943-71.7%

€503,191,074-5.7%

€533,686,078-8.1%

€581,063,866

€4,572,675+15.2%

€3,969,355+164.2%

€1,502,585-0.6%

€1,512,109

€150,557-100%

€382,347,252-12%

€434,717,486-8.9%

€477,117,043

€91,011,200-80.4%

€464,836,321-3.9%

€483,762,311+63.2%

€296,396,907

64.0%-30.7%

92.4%+1.9%

90.6%+77.7%

51.0%

€6,352,013-6.4%

€6,784,056-3.4%

€7,021,793

—

0.07+378.2%

0.01+0.6%

0.01

—

€51,195,742+33.5%

€38,354,754-23.2%

€49,923,767-82.5%

€284,666,959

0.56+581.7%

0.08-20%

0.10-89.2%

0.96

-361.97+41.1%

-614.51-115.8%

3895.56+130.1%

1692.84

Liquidity

€2,586,913-82.4%

€14,683,310-23.4%

€19,166,850-51%

€39,119,396

€14,043,403+71.7%

€8,177,892-57.4%

€19,205,123+22.3%

€15,704,428

€32,343,004+61.8%

€19,994,918+0.2%

€19,952,559-39.9%

€33,184,923

€39,702,881+48.1%

€26,815,046+8%

€24,836,521-29.5%

€35,211,432

1.71-4.4%

1.79+70.8%

1.05+598.2%

0.15

€34,349,548-13.1%

€39,552,670+86.7%

€21,182,582+110.4%

-€202,862,178

Efficiency

158 days-43.6%

279 days+804.9%

31 days+57.5%

20 days

Profit appropriation

€411,507,230

—

€913,3520%

€913,352

€40,832,691-90.1%

€411,507,230-3.5%

€426,641,333+80.3%

€236,640,489

iTeos Belgium

Activities

Financials

Frequently asked questions

All locations

All locations